chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within hours after the injection, I felt a sore throat and muscle aches. The muscle aches have lasted for the past two days, and I feel as though I have the flu. I was unable to pursue my normal routines, but had to stay in bed for the last two days. I have bronchial congestion that appears to be infected. Prior to the injection, I had no cold symptoms whatsoever. This appears to be a direct result of the vaccine.
Brain fog, depression, suicidal ideation, mild confusion, disorientation. Maximal 2 weeks but with < 50% improvement at 1 year.
Went to Emergency Department on 5/5/2003 because of chest pain. Chest pain described as sudden, radiating to entire torso, lasted 20 minutes. Was transported to ER by ambulence. EKG showed PVCs. Bloodwork was normal, Stress test on 5/6/2003 normal. Diagnosed with stress.
Rt. thigh, not where shot was given, crop of vesicles on red base 12 days after vaccine.
No adverse symptoms until the 8th day after the injection. Injection site became very red, raised, and warm to the touch.
No additional AE reported; an expired dose of MMR-II was administered to a patient; This spontaneous report as received from a medical assistant referring to an unspecified patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.   On 21-AUG-2023, the patient was vaccinated with expired mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA) lot # U024229 with expiration date 04-AUG-2023, for prophylaxis (strength, dose, route of administration and anatomical location were not reported) (Expired product administered). No additional adverse event (AE) was reported and also no adverse effects were reported. This is a non-valid case as no patient's identifiers were provided.   Follow up information has been received from a nurse practitioner regarding a 7-year-old male patient on 14-SEP-2023. The patient had non illness at time of vaccination nor pre-existing physician-diagnosed allergies, birth defects, medical conditions. The vaccine was purchased with public funds and the patient was vaccinated in a public health clinic.  On 21-AUG-2023, the patient was vaccinated with first expired mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant Human albumin (rHA) (lot # U024229 with expiration date 04-AUG-2023) (previously reported), administered subcutaneously through left arm. No previous doses of this vaccine was administered before.  Outcome for the event was reported as recovered. It was reported that at error occurred at the point of the administration of the vaccine. This event was reported previously to health department. The patient had no response to the administration of the expired vaccine.  This case was previously considered non-valid, but upon new follow-up information received patient's identifiers were provided.
Pt became listless, vomiting until next day; t103, arm swollen & red; color was very ash; lips, fingernails & feet bluish; pt taken to MD; pt was not urinating- problem was found w/kidneys; urine said to be infected;
Pt was admitted to hosp on 14NOV91 dx w/HIB meningitis; hx of fever & lethargy x 3 days; runny nose x 1 wk; t103;
shortness of breath; chest tightness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness). At the time of the report, DYSPNOEA (shortness of breath) and CHEST DISCOMFORT (chest tightness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Husband told nurse wife got MRSA from shot, suspected - upper bicep swollen, red, rash till 10/12 put NEOSPORIN on, hot, painful, could not raise arm. Fever 102, dizzy, pain (L) arm, mind cloudy, ache. Dizzy after shot 1 hour after, H/A, arm size grapefruit.
Mother called 9/5/06 to report allergic reaction to shots 8/31/06. Severe lump am 9/2/06 left arm, white center in bump. Took to Dr 9/2/06 and medications were given.
Woke up with extreme vertigo and sweating; Woke up with extreme vertigo and sweating; Could not lift head off of pillow due to dizziness; Fell back asleep/ Spent most of next four days in bed; Felt motion sick and tired; Felt motion sick and tired; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er2613) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 03:00, approximately 40 hours post second dose, the patient woke up with extreme vertigo and sweating and could not lift head off of pillow due to dizziness. The patient felled back asleep. Approximately 2 hours later, woke up with same symptoms. It was reported that the patient spent most of next four days in bed. The patient felt motion sick and tired. The patient went to the doctor and the doctor stated that patient had vertigo and told it would go away with time. Nine days later the patient finally felt about 80 percent better. Occasionally, the patient still had times of motion sickness. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events woke up with extreme vertigo and sweating, could not lift head off of pillow due to dizziness, fell back asleep/ spent most of next four days in bed and felt motion sick and tired was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Increased blood sugars up to the 300's for approximately 4-5 days after the injection.   Completely resolved after 5 days.
ELEVATED TEMP 101.4 DEGREES F ON 10/14/08 AND 104.5 DEGREES F ON 10/15/08.  GIVEN TYLENOL AND MOTRIN. SENT TO EMERGENCY DEPARTMENT AND THEN ADMITTED TO HOSPITAL WHERE HE REMAINS AT TIME OF REPORT. 10/31/08-records received for DOS 10/16-10/26/08-DC DX: Acute encephalopathy secondary to acute viral meningoencephalitis. Acute renal failure secondary to ischemic acute tubular necrosis which resolved once the dehydration was corrected. Hypotension with ischemic hepatitis which subsequently trended down to normal. Rhabdomyolysis. New diagnosis of Parkinson's disease. Hypernatremia secondary to dehydration. New diagnosis of right lower extremity deep vein thrombosis. Systemic inflammatory reactive syndrome secondary to hypotension, fever. Admitted with fever, decreased mentation, tachycardia, blood pressure of 56/36.
No additional AE; Caller is a HCP calling to report a TE for PNEUMOVAX 23.; This spontaneous report has been received from a registered nurse, concerning to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided.  On 08-MAR-2022, the patient was administered vaccine pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (valid lot number U022819 [expiration date 14-JAN-2023]) for prophylaxis, after a temperature excursion of 0.5 degrees Celsius (C) for 24 hours (product storage error) (dose, vaccination scheme, and frequency were not provided). Additionally, a previous temperature excursion was reported.  No additional adverse events (AE) were reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2206USA007070: US-009507513-2206USA006852: US-009507513-2206USA007090: US-009507513-2206USA006674: US-009507513-2206USA006674: US-009507513-2206USA006670: US-009507513-2206USA006731: US-009507513-2206USA006770: US-009507513-2206USA006952: US-009507513-2206USA006981: US-009507513-2206USA007045:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2006, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), by a physician as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
With the 1st vaccine (3/31/2021) about 15 minutes after I left and was driving home I felt like hundreds of ants were crawling up my back to my head and then all over my head. At the same time a single pitch of ringing in my left ear started and got louder and louder. I had not had tinnitus for years. I was driving in a silent car. This had never happened before. This loud ringing lasted for weeks.  With the 2nd vaccine on April 21, 2021 while I was still sitting in the Vaccine Clinic during the waiting period my wrists froze and I could not move them and then all of my other joints became stiff. I told this to the person in the clinic but she did nothing other then ask me if I was light headed or felt like I was going to faint - I told her I didn't feel light headed or that I was going to faint. She went away and said nothing more. After a while I left. This stiffness went away. Then 2 weeks later I started having terrible pain where I had partly torn my hamstring tendons and ruptured one in my other leg in August of 2019. I had done months of physical therapy January of 2020 had no pain and had been very active. There was no injury in April/May of 2021 that could explain the pain I was having. I started going back to PT and then a chiropractor. None of this helped. It was difficult because of covid to see doctors.
arm was a little sore; This is a spontaneous report from a contactable nurse (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 02Jan2021 (Lot number was not reported) as single dose, then dose 2 via an unspecified route of administration on 20Jan2021 (Lot number was not reported) as a single dose; both for covid-19 immunisation. Medical history included hypertension. Concomitant medication included nebivolol hydrochloride (BYSTOLIC) taken for hypertension, start and stop date were not reported. Patient had the Pfizer first shot (Covid19 vaccine Pfizer) and her arm was a little sore on an unspecified date and within the second time she got the shot, she rubbed it really hard. It was also mildly sore but neither shot, patient had any feelings of any sort. No side effects whatsoever other than arm. No treatment was given. Outcome of the event was unknown.  Information of lot/batch number has been requested.
Fever of 102.4, temperature is 100.4 today.; swollen lymph nodes in left armpit; chills; back body aches; headaches/ 7 days I am still experiencing headaches; I also do not feel myself like I am in a cloud; blood pressure is 140/107 today; This is a spontaneous report from a contactable consumer. A 39-years-old Non pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left (Age at vaccination39 years) on 18Mar2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in Arm Left on 01Apr2021 15:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included blood pressure measurement and No allergies. The patient's concomitant medications were not reported. Patient was not Pregnant at the time of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19. On 02-APR-2021 07:15, The patient experienced fever of 102.4, temperature is 100.4 today, swollen lymph nodes in left armpit, chills, back body aches, headaches/ 7 days i am still experiencing headaches, i also do not feel myself like i am in a cloud, blood pressure is 140/107 today. The patient underwent lab tests and procedures which included blood pressure measurement: 140/107   on 02Apr2021, body temperature: 100.4 on 02Apr2021, body temperature: 102.4 on Apr2021. No treatment was received. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given a flu vaccine on 08/24/17 and a second on 10/2/17.
Received Hepatitis A and B, Td, MMR aroound 1:00pm, around 3:00pm developed rash, itching on entire body.
I had the Pfizer vaccines and noticed excessive sweating and a strong smell under my arms. It was after my last vaccine when the event started. I have to change my clothes and wash my armpits frequently.  It is still smelling worse than prior to the vaccine but is a little less smelly. My 3rd vaccine, the booster was Sept 2021.
I received the Jannsen Covid Vaccine on April 05, 2021 at 08:50 am. On April 09,2021  at around 04:30 am I woke up with vaginal spotting. I had a full hysterectomy in 1999, 21 years ago. Alarmed. I took myself to urgent care. I was tested for a Urinary Tract Infection and a Yeast Infection by pelvic examination. Both tests were NEGATIVE. I was prescribed Diflucan 2 doses 150mg each to take 3 days apart. I discontinued the Diflucan upon learning of the negative result for yeast. April 10, 2021 I was still experiencing Vaginal bleeding upon waking up. April 11, 2021 the spotting had ceased.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Dec2021 at 14:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 26 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Cephalexin, reaction(s): "Known allergies:cephalexin". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid.Treatment start date:04Sep2022 and stop date: 08Sep2022.  Clinical course: Patient was given other medication in 2weeks, Walsom from 04Aug2022 tao 16sep2022 . Treatment start date:04Sep2022 and stop date: 08Sep2022. Foul taste in mouth, impact of taste of food, late period with no sexual activity while on daily birth control.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if  and when received.
Injection site reaction presenting possibly due to injection higher in the arm than it should be. Bright red and hot to touch. Improved by anti inflammatory oral Medications, unresolved by them entirely. Worsening at day 3 post injection.
Patient complaint of itchiness, shortness of breath,tongue swelling, hyperventilating. Epipen was administered at 3:20pm
Fever greater than 101F for 24 hours, severe joint pain, severe headache, fatigue. Treated over the counter with NyQuil, followed by Tylenol, which did not alleviate symptoms.
Unbearable headache, vertigo, vomiting, chills, sweats, 102 fever lasting over 24 hours
The day after her vaccine, she had a rash around the vaccine site; then day 2 post vaccine, the rash had extended from upper R arm across right breast to a line where the radiation from 2019 had stopped.   She spoke with her oncologist over the phone and was sent to urgent care to make sure there was no infection.  The dr agreed with her that this was probably another "radiation recall dermatitis."  There was no infection.     She was given an ointment at prompt care.  The rash resolved within 4 days.
pt was administered dose of vaccine that had been in the refrigerator longer than 6 hours, which is the longest per manufacturer guidelines.
Tingling and pins and needles throughout the body (head, arms, neck, back) occurred immediately post vaccination, patient was given 25mg of benadryl after 30 minute wait period and still reported tingling after 15 minutes. 30 minutes after benadryl no more tingling was reported.
COVID arm  - erythema, warmth and stinging/burning over left deltoid (injection site) with left arm paresthesias on day 2 of symptoms
having soreness in the arm where the vaccine was administered/ pain at the injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10-NOV-2023, the patient received the 2nd dose of Shingrix (intramuscular, unknown arm). On 10-NOV-2023, less than a day after receiving Shingrix, the patient experienced injection site pain (Verbatim: having soreness in the arm where the vaccine was administered/ pain at the injection site). The outcome of the injection site pain was not resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.     It was unknown if the company considered the injection site pain to be related to Shingrix.   Additional Information: GSK receipt date:10-NOV-2023 The reporter was the brother of the patient.  The reporter stated that the vaccine was administered at a local pharmacy. The reporter stated that patient had soreness in the arm where the vaccine was administered. The reporter stated that patient had pain at the injection site. It was unknown in which arm the vaccine was administered.  Lot and Expiry date were unknown.   No additional information was provided. Not all information was available.  Consent for follow up was not obtained.
Reaction at the injection site. Fatigue in general. Heat, burning and swelling at injection site.
pt recvd vax; devel redness,swelling,tenderness at inject site,lasted 2 days;
Patient was given pediatric pfizer 10MCG/0.2ML that was undiluted.  Patient's father was notified asked to watch for any adverse events such as sore arm, tiredness, fever.  Told father than if a severe reaction such as anaphylaxis occur to call 911.
This spontaneous prospective pregnancy report has been received from a registered nurse via a company representative referring to a 25 year old female patient. The patient had 27 weeks of gestation, her last menstrual period (LMP) was approximately on 29-SEP-2015, estimated date of conception was calculated to be on 13-OCT-2015 and due date to be on 05-JUL-2016; her medical history included that she was Rh negative and also a vaginal bleeding on 25-DEC-2015, when she went to the emergency department and confirmed that she was pregnant. Information regarding drug reactions or allergies were not known. On 05-APR-2016 the patient was mistakenly vaccinated with GARDASIL, intramuscular, (dose and frequency were not provided) lot # L039066 and expiration date 19-MAR-2017. The nurse reported that it was due to human error. Concomitant therapies included RHOGAM. No adverse effect reported or product quality complains involved. The nurse stated that the patient went to the office to seek medical attention and moreover, laboratory test were not specified by the reporter. Additional information has been requested.
My heart rate went high at resting and my oxygen went low for about 2 hours. It took 2 hours to come back down. My oxygen saturation was 92 and my heart rate was 159.
Per Mom - Patient has rash "all over" body. Booked her an appointment with Dr. to be seen on 10.30.08. Dx believes rash is not due to vaccines.
Facial flushing. Rash on arms and face. Wheezing. Cough. Tingling of tongue. Sx began approx. 30 min after inj.
Developed right deltoid pain and redness.  Also right head, neck, and right posterior flank band like severe sharp, burning, pain to very light touch.
Aside from the initial headache/achiness that I was told initially would accompany the vaccination, what has evolved since is much more concerning/grievous. Three (3) days after receiving the Janssen Johnson & Johnson Vaccine, I tried to participate in a community 5k. Being I have competed in multiple marathons, a 5K is a relatively simple task. At 1 mile I had to quit/withdraw because I was having something akin to an asthma attack and an extremely accelerated heart rate. I returned to my vehicle where I waited for my heart to return to a normal rate, but then began what can only be described as a coughing fit that lasted for close to 30 mins. Through that day and into the next, any physical exertion resulted in shortness of breath and accelerated heart rate. Example; walking up a flight of stairs. Or bending over to pick something up. Four (4) days after getting vaccinated I was walking down a ramp at a sporting event stadium, and again had something like an asthma attack, accompanied this time with significant chest pain under the right pectoral.  To date, 15 days later I cannot exert any physical effort, even something as simple as carrying in a small bag of groceries into my home without my heart accelerating and running out of breath, the way I would be formerly when sprinting to the finish of a long training run.
Vision changes and headaches began after vaccine. Diagnosed with temporal (giant cell) arteritis on 12/27/21.